INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Enochian Biosciences, Inc. (ENOB) on Behalf of Investors

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Law Offices of Howard G. Smith announces an investigation on behalf of Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB) investors concerning the Company’s possible violations of federal securities laws.

On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the inventor and co-founder of Enochian, had been arrested and charged in a murder-for-hire conspiracy.

On this news, Enochian’s stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, thereby injuring investors.

If you purchased Enochian securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  272.45
+1.28 (0.47%)
AAPL  292.25
+4.81 (1.68%)
AMD  441.95
+33.50 (8.20%)
BAC  51.48
-1.27 (-2.40%)
GOOG  394.09
-1.21 (-0.31%)
META  608.55
-8.26 (-1.34%)
MSFT  416.40
-4.37 (-1.04%)
NVDA  215.16
+3.66 (1.73%)
ORCL  194.60
+0.01 (0.01%)
TSLA  427.40
+15.61 (3.79%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.